BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 29071710)

  • 21. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.
    Wei Y; Yang J; Wang J; Yang Y; Huang J; Gong H; Cui H; Chen D
    Crit Care; 2016 Oct; 20(1):332. PubMed ID: 27751177
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.
    Laffin M; Millan B; Madsen KL
    Gut Microbes; 2017 May; 8(3):221-224. PubMed ID: 28059612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota and health.
    Kc D; Sumner R; Lippmann S
    Postgrad Med; 2020 Apr; 132(3):274. PubMed ID: 31566046
    [No Abstract]   [Full Text] [Related]  

  • 25. Faecal microbiota transplant - prospects and safety.
    Bartnicka A; Szachta P; Gałecka M
    Pomeranian J Life Sci; 2015; 61(3):282-6. PubMed ID: 27344870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
    Li YT; Cai HF; Wang ZH; Xu J; Fang JY
    Aliment Pharmacol Ther; 2016 Feb; 43(4):445-57. PubMed ID: 26662643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
    Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
    Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fecal microbiota transplantation: indications and perspectives].
    Lagier JC; Raoult D
    Med Sci (Paris); 2016 Nov; 32(11):991-997. PubMed ID: 28008840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
    Albarrak AA; Romana BS; Uraz S; Yousef MH; Juboori AA; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):929-935. PubMed ID: 30827274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The remedy within: will the microbiome fulfill its therapeutic promise?
    Thaiss CA; Elinav E
    J Mol Med (Berl); 2017 Oct; 95(10):1021-1027. PubMed ID: 28656322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
    Kerman DH
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic manipulation of the microbiota: past, present, and considerations for the future.
    Young VB
    Clin Microbiol Infect; 2016 Nov; 22(11):905-909. PubMed ID: 27619640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?
    Marrs T; Walter J
    Allergy; 2021 Jul; 76(7):2312-2317. PubMed ID: 33483999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota transplantation: concept, methodology and strategy for its modernization.
    Zhang F; Cui B; He X; Nie Y; Wu K; Fan D;
    Protein Cell; 2018 May; 9(5):462-473. PubMed ID: 29691757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor Considerations in Fecal Microbiota Transplantation.
    Barnes D; Park KT
    Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.
    Leshem A; Horesh N; Elinav E
    Front Immunol; 2019; 10():1341. PubMed ID: 31258528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durable coexistence of donor and recipient strains after fecal microbiota transplantation.
    Li SS; Zhu A; Benes V; Costea PI; Hercog R; Hildebrand F; Huerta-Cepas J; Nieuwdorp M; Salojärvi J; Voigt AY; Zeller G; Sunagawa S; de Vos WM; Bork P
    Science; 2016 Apr; 352(6285):586-9. PubMed ID: 27126044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.